NIH-funded research R01 grant

Understanding how asthma affects immune responses to COVID-19 in children

Official title: Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma

Funded at University of Virginia · NIH-11010411 · Data updated 2026-11-12

This study is looking at how kids with asthma react to COVID-19 and its vaccines by checking their immune system's response, so we can better understand how to protect them and improve their treatments.

More Asthma research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$678,376
NIH project number5R01AI176171-03
Project IDNIH-11010411 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years with asthma, particularly those who are poorly controlled and may be receiving high-dose corticosteroids.

Less likely to help

Patients without asthma or those over the age of 11 may not benefit from this research.

What this research studies

This research investigates how children with asthma respond to COVID-19 infections and vaccinations, focusing on their immune system's ability to fight off the virus and its variants. The study will analyze blood and respiratory samples to measure immune responses, including antibodies and T and B cell activity. By comparing children with asthma to healthy controls, the research aims to identify factors that influence immune responses in these at-risk populations. The findings could help improve vaccination strategies and treatments for children with asthma.

Why it matters

Potential benefit: If successful, this research could lead to better vaccination strategies and treatments for children with asthma, enhancing their protection against COVID-19.

How similar studies have gone: Other research has shown that understanding immune responses in at-risk populations can lead to significant advancements in treatment and prevention strategies.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Teague, William Gerald — University of Virginia
  • Study coordinator: Teague, William Gerald

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.